DALLAS, March 24, 2014 /PRNewswire/ -- Securities lawyers at Deans & Lyons announce an investigation of the board of Galena Biopharma, Inc. (NasdaqCM:GALE). Concerned GALE investors who purchased between November 6, 2013 and February 14, 2014 are encouraged to contact securities attorney Hamilton Lindley by clicking here.
"The complaint alleges that Galena Biopharma, Inc. failed to disclose or misrepresented that The Dream Team Group was hired to promote the share price of GALE, which according to the complaint purportedly allowed the CEO to sell $3.8 million worth of stock," said securities lawyer Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed to Galena Biopharma, Inc. shareholders."
Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@deanslyons.com or 877-819-8033 with questions or concerns.
Hamilton Lindley
DEANS & LYONS LLP
325 North Saint Paul Street, Suite 1500
Dallas, TX 75201
Phone: 214-736-7861
Fax: 214-965-8505
Toll-free: 877-819-8033
hlindley@deanslyons.com
www.deanslyons.com
SOURCE Deans & Lyons LLP
